Myeloproliferative Neoplasms News

COVID-19 remains a significant global burden, with 5 million worldwide deaths recorded as of October, according to a speaker at Chemotherapy Foundation Symposium.

Incorporation of next-generation sequencing into standard of practice will be required for patients with myelodysplastic syndrome and will impact all facets of care, according to a presenter at Chemotherapy Foundation Symposium.

Three individuals have been elected to American Society of Hematology’s executive committee.

Racial disparities in cancer clinical trial enrollment have existed for decades, with Black, Hispanic and other underserved populations prevented from accessing the same cutting-edge treatments as their white counterparts.

A collaborative team of cancer experts from leading academic institutions and organizations has released recommendations for optimal protection against COVID-19 among individuals with blood cancer.

American Association for Cancer Research urged the CDC to expand availability of COVID-19 booster vaccinations to caregivers and other individuals who share a home with patients with cancer.

September is Blood Cancer Awareness Month.

To advance health equity, it is time to normalize the collection of sexual orientation and gender identity (SOGI) data in clinical practice and in health services research.

Standard cancer care may fail to adequately address the needs of LGBTQ+ individuals, who face substantial disparities in access to screening, treatment and outcomes.

COVID-19 variants pose a greater threat to certain patients with cancer, particularly those with hematologic malignancies, confirming the need to promote vaccination within this population, according to data presented at ESMO Congress 2021.